Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Siminelakis, S., Kakourou A., Kakourou A., Batistatou A., Batistatou A., Sismanidis S., et al. (2014).  Thirteen years follow-up of heart myxoma operated patients: what is the appropriate surgical technique?. J Thorac Dis. 6 Suppl 1, S32-8.
Simitsopoulou, M., Roilides E., & Walsh T. J. (2011).  Immunomodulatory properties of antifungal agents on phagocytic cells.. Immunol Invest. 40(7-8), 809-24.
Simitsopoulou, M., Walsh T. J., Kyrpitzi D., Petraitis V., Kontoyiannis D. P., Perlin D. S., et al. (2015).  Methylprednisolone impairs conidial phagocytosis but does not attenuate hyphal damage by neutrophils against Exserohilum rostratum.. Med Mycol. 53(2), 189-93.
Simitsopoulou, M., Roilides E., Georgiadou E., Paliogianni F., & Walsh T. J. (2011).  Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus.. Med Mycol. 49(2), 176-85.
Simitsopoulou, M., Chlichlia K., Kyrpitzi D., Walsh T. J., & Roilides E. (2018).  Pharmacodynamic and Immunomodulatory Effects of Micafungin on Host Responses against Biofilms of Candida parapsilosis in Comparison to Those of Candida albicans.. Antimicrob Agents Chemother. 62(8), 
Simitsopoulou, M., Kyrpitzi D., Velegraki A., Walsh T. J., & Roilides E. (2014).  Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.. Antimicrob Agents Chemother. 58(8), 4953-6.
Simitsopoulou, M., Georgiadou E., Walsh T. J., & Roilides E. (2010).  Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp.. Med Mycol. 48(5), 720-4.
Simmons, A., Westman E., Muehlboeck S., Mecocci P., Vellas B., Tsolaki M., et al. (2011).  The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months.. Int J Geriatr Psychiatry. 26(1), 75-82.
Simmons, A., Westman E., Muehlboeck S., Mecocci P., Vellas B., Tsolaki M., et al. (2009).  MRI measures of Alzheimer's disease and the AddNeuroMed study.. Ann N Y Acad Sci. 1180, 47-55.
Simoncini, T., Cano A., Goulis D. G., Lambrinoudaki I., Rees M., & Stute P. (2019).  On the use and abuse of register studies: The case of menopausal hormone therapy.. Maturitas. 123, 91-92.
Sinakos, E., Marschall H-U., Kowdley K. V., Befeler A., Keach J., & Lindor K. (2010).  Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.. Hepatology. 52(1), 197-203.
Sinakos, Ε., Gioula G., Liava C., Papa A., Papadopoulou E., Tsakni E., et al. (2018).  Prevalence of hepatitis E in liver transplant recipients in Greece.. Epidemiol Infect. 146(13), 1619-1621.
Sinakos, E., Saenger A. K., Keach J., W Kim R., & Lindor K. D. (2011).  Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma.. Clin Gastroenterol Hepatol. 9(5), 434-9.e1.
Sinakos, E., Dedes I., Papalavrentios L., Drevelegas A., & Akriviadis E. (2010).  Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma.. Scand J Gastroenterol. 45(4), 511-2.
Sinakos, E., Gigi E., Lalla T., Bellou A-L., Sykja A., Orphanou E., et al. (2010).  Health-related quality of life in Greek chronic hepatitis C patients during pegylated interferon and ribavirin treatment.. Hippokratia. 14(2), 122-5.
Sinakos, E., Abbas G., Jorgensen R. A., & Lindor K. D. (2012).  Serum lipids in primary sclerosing cholangitis.. Dig Liver Dis. 44(1), 44-8.
Sinakos, E., Panas P., Fragkou N., Antoniadis N., Katsanos G., Tsakni E., et al. (2022).  Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease.. Acta Gastroenterol Belg. 85(2), 331-337.
Sinakos, E., Selvaggi G., Papalavrentios L., Tzakis A., & Akriviadis E. (2011).  The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence.. Ann Gastroenterol. 24(3), 228-230.
Sinakos, E., & Lindor K. D. (2010).  Bile acid profiles in intrahepatic cholestasis of pregnancy: is this the solution to the enigma of intrahepatic cholestasis of pregnancy?. Am J Gastroenterol. 105(3), 596-8.
Sinakos, E., Perifanis V., Vlachaki E., Tsatra I., & Raptopoulou-Gigi M. (2010).  Is liver stiffness really unrelated to liver iron concentration?. Br J Haematol. 150(2), 247-8.
Sinakos, E., Kountouras D., Koskinas J., Zachou K., Karatapanis S., Triantos C., et al. (2017).  Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.. Br J Haematol. 178(1), 130-136.
Sinakos, E., Papalavrentios L., Chourmouzi D., Dimopoulou D., Drevelegas A., & Akriviadis E. (2011).  The clinical presentation of Von Meyenburg complexes.. Hippokratia. 15(2), 170-3.
Sinakos, E., Samuel S., Enders F., Loftus E. V., Sandborn W. J., & Lindor K. D. (2013).  Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship.. Inflamm Bowel Dis. 19(5), 1004-9.
Sinakos, E., Vlachaki E., & Tsapas A. (2012).  Safety of deferasirox in sickle cell disease patients with co-existing liver impairment.. Br J Haematol. 157(4), 505-6; author reply 506-7.
Sinakos, E., Hytiroglou P., Chourmouzi D., & Akriviadis E. (2015).  Focal nodular hyperplasia in an individual with Abernethy malformation type 1b.. Dig Liver Dis. 47(12), 1089.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές